The analysis of the tumors showed a significant increase in total CD8 T cells and tumor antigen‐specific Gp‐70‐pentamer+ CD8 T cells in the combination treatment group as compared to controls treated with isotype‐matched irrelevant mAbs and mice receiving a single treatment with anti‐NKG2A/Qa‐1b or with NK cells (Fig 3C and D). The gene discussed is CD8A; the disease is neoplasm.